Medwin Hospital, Hyderabad, AP, India Report issue

Academic/Hospital Phase 2 Phase 3

Organization Overview

First Clinical Trial
2005
NCT00500409
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Medwin Hospital

Active Ingredients

Drugs in Phase 3 Trials (3)

calcium (1 trial)

parathyroid hormone (Natpara) (1 trial)

vitamin d3 (1 trial)

Drugs in Phase 2 Trials (3)

arhalofenate (1 trial)

pioglitazone (actos) (1 trial)

sitagliptin (januvia) (1 trial)

Drugs in Other Trials (1)

adapalene (differin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus (Phase 2)

Diabetes Mellitus, Type 2 (Phase 2)

Osteoporosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 7